Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis

Maria D'Amato, Francesco Menzella, Elena Altieri, Elena Bargagli, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Fausto De Michele, Fabiano Di Marco, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Alessandra Vultaggio, Alessandra Ori, Lucia Simoni, Silvia Boarino, Gianfranco Vitiello, Maria Aliani, Stefano Del Giacco

Open source

DOI
10.3389/falgy.2022.881218
Published
2022-05-18
Container
Frontiers in Allergy
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/falgy.2022.881218,
  title = {Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis},
  author = {Maria D'Amato and Francesco Menzella and Elena Altieri and Elena Bargagli and Pietro Bracciale and Luisa Brussino and Maria Filomena Caiaffa and Giorgio Walter Canonica and Cristiano Caruso and Stefano Centanni and Fausto De Michele and Fabiano Di Marco and Elide Anna Pastorello and Girolamo Pelaia and Paola Rogliani and Micaela Romagnoli and Pietro Schino and Gianenrico Senna and Alessandra Vultaggio and Alessandra Ori and Lucia Simoni and Silvia Boarino and Gianfranco Vitiello and Maria Aliani and Stefano Del Giacco},
  year = {2022},
  journal = {Frontiers in Allergy},
  doi = {10.3389/falgy.2022.881218},
  url = {https://doi.org/10.3389/falgy.2022.881218}
}

RIS

TY  - JOUR
TI  - Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
AU  - Maria D'Amato
AU  - Francesco Menzella
AU  - Elena Altieri
AU  - Elena Bargagli
AU  - Pietro Bracciale
AU  - Luisa Brussino
AU  - Maria Filomena Caiaffa
AU  - Giorgio Walter Canonica
AU  - Cristiano Caruso
AU  - Stefano Centanni
AU  - Fausto De Michele
AU  - Fabiano Di Marco
AU  - Elide Anna Pastorello
AU  - Girolamo Pelaia
AU  - Paola Rogliani
AU  - Micaela Romagnoli
AU  - Pietro Schino
AU  - Gianenrico Senna
AU  - Alessandra Vultaggio
AU  - Alessandra Ori
AU  - Lucia Simoni
AU  - Silvia Boarino
AU  - Gianfranco Vitiello
AU  - Maria Aliani
AU  - Stefano Del Giacco
PY  - 2022
JO  - Frontiers in Allergy
DO  - 10.3389/falgy.2022.881218
UR  - https://doi.org/10.3389/falgy.2022.881218
ER  - 

APA

D'Amato, M., Menzella, F., Altieri, E., Bargagli, E., Bracciale, P., Brussino, L., Caiaffa, M. F., Canonica, G. W., Caruso, C., Centanni, S., Michele, F. D., Marco, F. D., Pastorello, E. A., Pelaia, G., Rogliani, P., Romagnoli, M., Schino, P., Senna, G., Vultaggio, A., Ori, A., Simoni, L., Boarino, S., Vitiello, G., Aliani, M., & Giacco, S. D. (2022). Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis. Frontiers in Allergy. https://doi.org/10.3389/falgy.2022.881218

Source records